The Fruits of Comparative Effectiveness
New CER tools grant payers the evidence they need to control drug costs
Country Report: The Philippines
Once silent, an emerging market raises its voice
Science and Politics at the FDA
Harvard professor Daniel Carpenter offers a piercing analysis of the FDA and sheds light on its biggest challenges
Japan: The Real Emerging Market?
With all the money and momentum focused on medicines in emerging markets, it may be time to take a closer look at business opportunities in this more familiar neighbor to the East
Specialty Care Medicines: Managing the Impact of US Health Reform
There's been much talk of how US health reform will impact physicians, patients, and insurance companies. But how will it affect the often overlooked specialty drug market?
Pharma's Identity, From I to T
The FDA process itself is looking more like the unsavory 'sausage factory' associated with drafting partisan legislation
Regional Marketing, National Growth
Pharm Exec sits down with an expert on regional marketing to ascertain what it takes to drive strong brand results
How the FDA Grew
A timeline of some of the landmark legislation, court decisions, and drug scandals that helped forge the FDA
